Holding Our Breath—Looking for Treatments for Mild to Moderate COVID-19
- 1 October 2024
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (10) , e2439283
Abstract
Mild COVID-19 therapeutics with guideline support currently are limited to options for those who are at high risk of disease progression and have a lowerKeywords
This publication has 4 references indexed in Scilit:
- Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs PlaceboJAMA Network Open, 2024
- In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE projectThe Lancet Regional Health - Europe, 2024
- ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19Journal of Clinical and Translational Science, 2023
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Clinical Infectious Diseases, 2022